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The PDGF/VEGF Receptor Controls
Blood Cell Survival in Drosophila
vertebrate development. Two independent waves of he-
matopoiesis can be distinguished: First, embryonic he-
mocytes arise from the procephalic mesoderm, a spe-
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cytes.
Similar to the vertebrate hematopoietic system, theThe Drosophila PDGF/VEGF receptor (PVR) has known
Drosophila blood cell system comprises myeloid cells,functions in the guidance of cell migration. We now
but in contrast to vertebrates lacks a lymphoid branch.demonstrate that during embryonic hematopoiesis,
At least three different blood cell lineages can be distin-PVR has a role in the control of antiapoptotic cell sur-
guished (Lanot et al., 2001; Rizki, 1978): Macrophages,vival. In Pvr mutants, a large fraction of the embryonic
or plasmatocytes, phagocytose apoptotic corpses andhemocyte population undergoes apoptosis, and the
bacteria, and represent the majority of hemocytes bothremaining blood cells cannibalistically phagocytose
in the embryo (Tepass et al., 1994) and during latertheir dying peers. Consequently, total hemocyte num-
stages of development (Lanot et al., 2001). Crystal cells,bers drop dramatically during embryogenesis, and
which mediate melanization during encapsulation oflarge aggregates of engorged macrophages carrying
parasites or wounding, form a minor fraction of hemo-multiple apoptotic corpses form. Hemocyte-specific
cytes from embryonic stages onward (Lebestky et al.,expression of the pan-caspase inhibitor p35 in Pvr
2000). Finally, lamellocytes differentiate during encap-mutants eliminates hemocyte aggregates and re-
sulation and metamorphosis, but are not present in thestores blood cell counts and morphology. Additional
embryo or adult (Lanot et al., 2001; Rizki and Rizki, 1992).rescue experiments suggest involvement of the Ras
Genetic analysis of Drosophila hematopoiesis has re-pathway in PVR-mediated blood cell survival. In cell
vealed similarities with mammalian hematopoiesis at theculture, we demonstrate that PVR directly controls
molecular level (Evans et al., 2003; Fossett and Schulz,survival of a hemocyte cell line. This function of PVR
2001). Still, major questions remain to be answered. Forshows striking conservation with mammalian hemato-
example, while in mammalian biology trophic survivalpoiesis and establishes Drosophila as a model to study
of cells inside and outside the hematopoietic system ishematopoietic cell survival in development and disease.
a recurring theme (Raff et al., 1993), such pathway(s)
involved in Drosophila embryonic and larval blood cellIntroduction
survival have not been identified yet.
In vertebrates, Receptor Tyrosine Kinases (RTKs) areStudies in recent years have highlighted the similarity
important players that transduce trophic cues in manybetween the Drosophila blood cell system and the he-
systems (Jacobson et al., 1997). Members of the PDGFmatopoietic system of vertebrates (Evans et al., 2003).
and VEGF RTK families have been studied in numerousDrosophila blood cells, or hemocytes, participate in in-
in vitro and cell culture systems and have been impli-nate immunity (Hoffmann and Reichhart, 2002), have
cated in cell survival and other cellular responses suchimportant functions in the removal of apoptotic cells
as proliferation and differentiation (Hoch and Soriano,(Abrams et al., 1993; Franc, 2002; Franc and White, 2000;
2003). Mouse genetics has demonstrated a requirementTepass et al., 1994), and produce extracellular matrix
for these RTKs in multiple hematopoietic lineages: c-Kitcomponents (Nelson et al., 1994).
in multipotent stem/progenitor cells, mast cell, ery-During Drosophila development, generation of blood
throid, and other lineages (Ashman, 1999); VEGFR2cells occurs at different physical locations (Evans et al.,
(KDR, Flk1) in the earliest hematopoietic/angioblastic2003), similar to the shift of hematopoietic sites during
precursors (Ferrara and Davis-Smyth, 1997); and c-Fms
(CSF-1R, M-CSFR) in the monocyte-macrophage lin-
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al., 2002; Waskow et al., 2002). Improved characteriza- homozygous embryos displayed large clusters of mac-
rophages (Figure 1C). Embryos homozygous for Pvr4tion of these in vivo functions is desirable, since hyper-
activation of PDGF/VEGF receptors (PVR) is frequently showed macrophage aggregates at later stages (Figure
1G), consistent with the hypomorphic character of thisassociated with tumorigenesis and leukemogenesis
(Scheijen and Griffin, 2002) and the underlying mecha- allele. In both Pvr1 and Pvr4, phenotypes increased in
severity over time (Figures 1I and 1J). Interestingly, clus-nisms are being debated (Gerber and Ferrara, 2003;
Kelly and Gilliland, 2002). tered macrophages showed intensified Crq staining, in-
dicative of elevated phagocytic activity (Franc et al.,Drosophila embryonic hematopoiesis offers a number
of experimental advantages: (1) Blood cell proliferation 1999). Staining with anti-Lz antibody (Lebestky et al.,
2000) revealed no obvious effect of Pvr loss-of-functionis separated in time from other developmental events
such as blood cell migration, differentiation, and sur- on crystal cells (data not shown). Taken together, our
results indicate that in the absence of PVR activity, em-vival. With the exception of a small number of crystal
cell precursors (Lebestky et al., 2000), blood cell prolifer- bryos display defects in hemocyte distribution and bear
anterior macrophage aggregates with elevated Crq ex-ation is largely completed by stage 11, resulting in about
600–700 blood cells per embryo. Subsequently, blood pression.
cells migrate out of the anterior area where they origi-
nated, and a large number of hemocytes differentiate Hemocyte Aggregation Is Blood Cell Autonomous
into macrophages (Tepass et al., 1994). (2) Drosophila To test whether the Pvr mutant phenotype was blood
has a low genomic complexity. Only a single PDGF/ cell autonomous, we wanted to use a GAL4 line that
VEGF receptor is encoded by the genome (Cho et al., drives hemocyte-specific expression of UAS transgenes
2002; Duchek et al., 2001; Heino et al., 2001), thus (Brand and Perrimon, 1993). As none of the available
allowing analysis without genetic redundancy. GAL4 lines was sufficiently specific and active at all
Previously, PVR was shown to mediate guidance of stages of embryonic hemocyte development, we con-
border cell migration in the Drosophila egg chamber structed srpHemoGAL4 based on selected regulatory
(Duchek et al., 2001; McDonald et al., 2003). Likewise, regions of serpent (srp), a GATA factor essential for all
initial reports implicated PVR and its ligands PVF1-3 in embryonic blood cell development (Rehorn et al., 1996).
embryonic hemocyte migration (Cho et al., 2002; Heino The expression pattern of srpHemoGAL4 driving UAS-
et al., 2001). Here, we dissect the functions of PVR during EGFP was compared to stainings for Crq and the hemo-
embryonic development and investigate parallels be- cyte/macrophage marker Peroxidasin (Pxn) (Abrams et
tween the Drosophila and vertebrate hematopoietic sys- al., 1993; Nelson et al., 1994). srpHemoGAL4 activity
tem. Isolating and analyzing Pvr mutants, we demon- was highly specific for blood cells, as EGFP expression
strate that the predominant role of PVR in the Drosophila was detected in procephalic mesoderm of stage 9 em-
embryo is to mediate trophic survival of blood cells. Cell bryos and hemocytes/macrophages of all embryonic
culture experiments with a Drosophila hemocyte cell stages thereafter (Figures 2A and 2B and data not
line confirm direct control of cell survival by PVR. shown). Double stainings with Lozenge (Lz) (Lebestky
et al., 2000) showed that srpHemoGAL4 is also active
in the crystal cell lineage (Figure 2C). Importantly, srpHe-Results
moGAL4 activity matches the hemocyte expression do-
main of PVR (Figures 2D–2E).Pvr Mutant Embryos Form
To determine whether the Pvr mutant phenotype isMacrophage Aggregates
blood cell autonomous, we used srpHemoGAL4 to ex-Previously, in situ hybridizations showed high expres-
press PVRC, a dominant-negative form of PVR thatsion of Pvr mRNA in embryonic hemocytes (not shown
lacks the entire cytoplasmic domain of the receptor.and Cho et al., 2002; Heino et al., 2001). To determine
Ubiquitous expression of PVRC induced hemocyte ag-which subpopulation of the embryonic hemocytes ex-
gregation as seen in Pvr mutants, consistent withpresses PVR protein, immunohistochemical stainings
PVRC dominantly interfering with endogenous PVR ac-for PVR and known blood cell markers were done. Begin-
tivity (data not shown). Hemocyte-specific disruption ofning at stage 10 of embryonic development, PVR protein
PVR signaling was sufficient to mimic Pvr loss of func-was highly expressed in a hemocyte-specific pattern.
tion: Embryos showed the typical blood cell aggregationThe macrophage marker Croquemort (Crq) (Franc et al.,
phenotype from stage 14 onward (Figure 2F). Expression1996) colocalized with virtually all strongly PVR-positive
of PVRC by srpHemoGAL4 was lethal, resembling thecells (Figure 1A), indicating that PVR is expressed in the
lethality associated with the Pvr mutant phenotype.macrophage lineage.
These findings demonstrate that the hemocyte aggrega-To isolate Pvr loss-of-function mutations, we con-
tion phenotype seen upon decrease of PVR signaling isducted an EMS mutagenesis. Seven independent alleles
cell autonomous and is based on an inherent bloodwere recovered from this screen (Pvr1-7, see Supple-
cell defect.mental Data at http://www.developmentalcell.com/cgi/
content/full/7/1/73/DC1). Using in situ hybridizations of
embryos and antibody staining in follicle cell clones, Ectopically Induced Hemocyte Apoptosis
Phenocopies Pvr Loss of FunctionPVR mRNA and protein was detected with Pvr4 but not
with Pvr1(data not shown), suggesting that Pvr1 is a com- To determine the basis of the hemocyte defect associ-
ated with loss of Pvr activity, we expressed variousplete null and that Pvr4 might be a hypomorphic allele.
We analyzed the Pvr mutant phenotype by staining UAS lines under control of srpHemoGAL4 (Supplemental
Figure S1A). Blood cell aggregation was assessed bymacrophages with anti-Crq antibody. By stage 12, Pvr1
PVR Controls Blood Cell Survival
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Figure 1. Pvr Mutants Show Macrophage Defects
(A) PVR is expressed in embryonic macrophages. Antibody staining for PVR (red) and Crq (green). PVR expression is highest in macrophages.
Low-level expression is observed in the developing tracheal system (not shown) and the epidermis. PVR is not expressed in additional Crq
expression domains such as the amnioserosa. Stage 14 embryo, dorsal-lateral view, anterior to the left. For technical reasons, genotype is
lzGAL4, UAS-EGFP.
(B–J) Hemocyte distribution in wild-type and Pvr mutant embryos. (B–D) Stage 12 dorsal-lateral view, (E–G) stage 14 lateral view, (H–J) stage
16 dorsal view, anterior to the left. Hemocytes are visualized by anti-Crq (low-level staining of gut and amnioserosa). Central focal planes of
embryos were selected. Pvr mutants (Pvr1 in [C], [F], [I] and Pvr4 in [D], [G], [J]) display large macrophage aggregates (in regions of the
amnioserosa, head, and proventriculus; see brackets), while hemocytes of wild-type control (w1118) embryos (B, E, and H) are evenly dispersed.
Blood cell aggregation becomes obvious around stage 12 in Pvr1 and stage 14 in Pvr4. Hemocytes do not enter the posterior end (arrowhead
in [C] and [D]) and appear sparse or absent in ventral-posterior areas at later stages (arrowhead in [F] and [G]).
Crq antibody staining (Figure 3, Supplemental Figure apoptotic corpses (Figures 3E–3G). These observations
suggest that loss of PVR signaling may lead to an in-S1, and data not shown).
Previously, expression of PVR, a constitutively active crease in blood cell death, similar to the hemocyte death
induced by ectopic expression of the proapoptotic geneform of PVR, was shown to arrest border cell migration in
female egg chambers, reflecting requirement for locally HIDala5. As a consequence, dead blood cells may be
phagocytosed by still viable peers, resulting in the ob-asymmetric receptor activation in border cell guidance
(Duchek et al., 2001). In contrast, we found that hemo- served increase in incorporated apoptotic corpses. This
hypothesis of “cannibalistic phagocytosis” is supportedcyte-specific expression of PVR did not result in blood
cell aggregation (Figure 3C) and did not affect adult by elevated levels of Crq protein (Figures 1 and 3), indi-
cating enhanced phagocytic activity of hemocytesviability. A low percentage of embryos showed a mild
deficiency of hemocytes in the ventral-posterior region (Franc et al., 1999).
(Figure 3C) and in the posterior end of the elongated
germ band (data not shown). Despite these minor irregu-
larities in blood cell distribution, we conclude that uni- Pvr Mutant Macrophage Aggregates Result
from Apoptotic Blood Cell Deathform activation of PVR does not cause hemocytes to
form aggregates. and Cannibalistic Phagocytosis
To test our hypothesis, we sought a method to demon-Among all lines tested, we found that only the proapo-
ptotic Head Involution Defect (HID) in its nonrepressable strate apoptosis of hemocytes. A major function of mac-
rophages is to phagocytose dead cells. Therefore, apo-ala5 version (Bergmann et al., 1998) induced a macro-
phage aggregation phenotype similar to dominant-neg- ptotic stains like TUNEL or acridine orange do not
distinguish between phagocytosed apoptotic corpsesative PVRC (Figures 3B and 3D). When HIDala5 was
expressed, blood cell clusters appeared at earlier naturally occurring within macrophages and phagocy-
tosed dead hemocytes themselves. We therefore chosestages, but resembled the Pvr loss-of-function pheno-
type: Hemocytes had fewer extensions, were dramati- an alternative approach to test our hypothesis in vivo.
By coexpressing nuclear -gal and cytoplasmic EGFPcally enlarged, and carried multiple inclusions typical for
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Figure 2. The Pvr Macrophage Aggregation
Phenotype Is Blood Cell Autonomous
(A–C) Colocalization of the hemocyte-spe-
cific driver srpHemoGAL4 with known blood
cell markers. Genotype srpHemoGAL4, UAS-
srcEGFP. (A) EGFP (green) colocalizes with
Crq (red). Stage 14 embryo, lateral view.
Other Crq expression domains such as am-
nioserosa and gut do not show colocaliza-
tion. (B) EGFP (green) colocalizes with Pxn
(red). Stage 16 embryo, dorsal view. (C) Lz-
positive cells (red) are EGFP positive. Stage
14 embryo, lateral-dorsal view, single opti-
cal section.
(D and E) srpHemoGAL4 driven UAS-lacZ-nls
(nuclear -gal, red) marks the same set of
blood cells that expresses PVR (green) from
stage 10/11 onward. (D) Stage 11, dorsal
view. (E) Stage 14, lateral view. In contrast to
the srp gene (Rehorn et al., 1996), srpHemo-
GAL4 does not drive expression in other tis-
sues, such as midgut primordia and the amni-
oserosa, and shows only marginal expression
in some areas of the fat body.
(F) Hemocyte-specific expression of domi-
nant-negative PVRC phenocopies Pvr loss
of function. Embryos srpHemoGAL4/; UAS-PVRC/, stained with anti-Crq. Dorsal view of a stage 16 embryo (central focal plane) is shown.
Bracket marks anterior accumulation of macrophage aggregates. Hemocyte aggregation prior to stage 14 is less obvious, presumably due
to a lag in the production of sufficient levels of PVRC protein. When the early mesodermal driver twiGAL4 is used, hemocyte aggregates
appear at earlier stages (not shown).
using the hemocyte-specific srpHemoGAL4, we differ- activate one another in a proteolytic cascade and medi-
ate the breakdown of other cellular proteins (Danial andentially marked the nuclei and cytoplasmic compart-
ment of hemocytes in wild-type and Pvr mutant embryos Korsmeyer, 2004). We asked whether hemocyte-spe-
cific expression of the baculovirus p35 pan-caspase(Figure 4). This staining allowed us to determine whether
hemocytes would maintain single -gal-positive nuclei inhibitor (Hay et al., 1994) would be sufficient to rescue
the Pvr1 mutant phenotype. Indeed, expression of p35or whether they would accumulate multiple -gal-posi-
tive inclusions indicative of incorporating hemocytes eliminated macrophage clusters, and blood cells were
distributed evenly throughout anterior and dorsal areasthat were dying. Further, it allowed us to quantify labeled
hemocytes and visualize nuclear morphology as an indi- (Figure 4B). Hemocytes carried single -gal-marked nu-
clei that showed no signs of nuclear fragmentation orcator of apoptotic fragmentation and cell death (Abrams
et al., 1993; Jacobson et al., 1997). loss of nuclear integrity (Figures 4K and 4L). Despite
these dramatic improvements, some minor abnormali-Wild-type embryos showed evenly distributed blood
cells, each with a single -gal-positive nucleus (Figure ties in hemocyte distribution remained (Figure 4B),
which point to residual survival-independent functions4H). In Pvr1 mutant embryos, hemocytes appeared
sparse and localized to clusters (Figure 4A). As pre- of PVR in cell migration and/or invasion (see Figure 7).
Nevertheless, we conclude that the predominant defectdicted for a macrophage that has engulfed other dying
hemocytes, we found that many EGFP-marked hemo- in Pvr loss-of-function hemocytes is a lack of trophic
survival.cytes contained multiple -gal-positive inclusions. Typi-
cal hallmarks of programmed cell death, such as nuclear
fragmentation, were seen (Figures 4I and 4J). In many Activated RTK Signaling Mediators Rescue
Hemocyte Death and Aggregationcases, -gal staining expanded to structures beyond
normal nuclear size and colocalized with EGFP, presum- PVR may trigger a number of signaling pathways to
promote trophic blood cell survival. One candidate is theably due to a loss of nuclear integrity and diffusion of
the -gal and EGFP proteins (Peterson et al., 2003). An Ras/MAPK pathway, as PVR signaling induces MAPK
activation in Schneider cells (Duchek et al., 2001) andantibody against the cleaved form of Caspase 3 was
used as a marker for apoptotic cells. It costained with correlates with MAPK activation in embryonic blood
cells (Cho et al., 2002). MAPK signaling was shown to-gal and EGFP in some hemocytes of Pvr1, but not
wild-type embryos (Figures 4M and 4N). Taking the data suppress apoptosis of both HID-induced photoreceptor
death and naturally occurring apoptosis of midline gliatogether, we conclude that hemocytes in Pvr mutant
embryos phagocytose dying hemocytes, consistent (Bergmann et al., 1998, 2002) and smooth cuticle cells
(Urban et al., 2004). By analogy with mammalian PDGF/with cannibalistic phagocytosis.
To revert apoptotic hemocyte death and cannibalistic VEGF receptors, PVR may also activate the PI3K/Akt
pathway, which mediates trophic survival of mammalianphagocytosis, we coexpressed antiapoptotic rescue
transgenes (Figures 4 and 5). Apoptotic cell death is cells (Franke et al., 1997) and promotes cell survival
during Drosophila embryogenesis (Scanga et al., 2000).executed by the action of a family of caspases, that
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was comparable to p35 alone (Figure 4F). In all rescues
by p35 or activated signaling components, we noted
persistence of local abnormalities in hemocyte distribu-
tion in the ventral-posterior area (Figures 4B–4F) and at
the posterior end during germ band elongated state
(data not shown). No defects in blood cell distribution
remained when Pvr mutants were rescued by hemocyte-
specific expression of wild-type PVR (Figure 4G). Thus,
we conclude that uniformly activated PVR is sufficient
to rescue blood cell death and aggregation associated
with Pvr mutants, although it may fail to substitute for
an additional function(s) of PVR that would require differ-
ential activation of the receptor (see Figure 7). Activated
Ras rescues Pvr dependent hemocyte death and aggre-
gation, suggesting that signaling through the Ras path-
way may be a route of PVR-mediated trophic cell sur-
vival.
To confirm hemocyte loss and quantify the effect of
coexpressed rescue transgenes, we analyzed embry-
onic blood cell numbers. Hemocytes were counted in
embryos at stage 11/12, and subsequently at stage 15/
16, to analyze stability of cell numbers over time. Initial
blood cell counts of wild-type embryos and embryos
with hemocyte expression of PVRC were comparable.
At stage 15/16, however, counts of PVRC hemocytes
had dropped to about 50% of wild-type (Figure 5), con-
sistent with cell loss due to apoptotic death. In Pvr1
homozygous mutants, hemocyte numbers were alreadyFigure 3. Hemocyte Death, but Not Uniform PVR Activation, Leads
to Blood Cell Aggregation reduced at stage 11/12, and dropped further over time.
(A–D) Wild-type control embryo (A) and embryos expressing trans- Asking whether the early reduction in blood cell counts
genes under control of srpHemoGAL4. Staining with anti-Crq, stage was due to an impairment of hemocyte proliferation or
16 lateral view. (B) Dominant-negative PVRC (srpHemoGAL4/; early apoptotic cell death, we coexpressed the baculovi-
UAS-PVRC/) induces hemocyte aggregation in the anterior re- rus p35 pan-caspase inhibitor. Consistent with hemo-
gion (bracket) and around the proventriculus (arrowhead). (C) Uni-
cyte morphology and distribution (Figures 4B, 4K, andform hemocyte-specific expression of activated PVR (srpHemo-
4L), p35 expression was sufficient to restore initial bloodGAL4/; UAS-PVR /, or srpHemoGAL4/UAS-PVR, not shown)
cell numbers to almost wild-type, indicating that zygoticdoes not result in blood cell aggregation. In 20% (UAS-PVR on III)
and 45% (UAS-PVR on II) of stage 16 embryos, cell distribution PVR is not required for embryonic hemocyte prolifera-
was mildly aberrant with fewer cells in the ventral-posterior area tion. Blood cell counts diminished slightly over time,
(arrowhead). Earlier expression of PVR by the mesodermal driver suggesting that under the experimental conditions used,
twiGAL4 results in a comparably mild hemocyte distribution defect p35 did not block cell death completely. Uniform activa-
(not shown). (D) UAS-HIDala5/; srpHemoGAL4/). Hemocyte aggre-
tion of PVR signaling by PVR resulted in an efficientgates (bracket) are found in the head region, around the proventricu-
rescue of blood cell counts, and coexpression of acti-lus (arrowhead), and in areas of the amnioserosa or gut.
vated RasV12 had comparable effects (Figure 5). The acti-(E–G) Hemocyte morphology. Hemocytes were marked by srpHe-
moGAL4, UAS-srcEGFP, and anti-EGFP staining. Single optical sec- vated form of the PI3K catalytic subunit, p110CAAX, was
tions of comparable regions in the anterior region of stage 16 em- not potent in Pvr rescues when stage 15/16 embryos
bryos are shown. (E) Wild-type background, (F) expression of were inspected (Figure 4E), while at early stages partial
PVRC, (G) expression of HIDala5. rescue of blood cell counts was seen (Figure 5). Combin-
ing expression of the two partially rescuing transgenes
p35 and p110CAAX had only marginally additive effects
We therefore tested activated RasV12 and an activated (Figure 5). Taking the data together, we conclude that
form of the PI3K catalytic subunit, p110CAAX, for their Pvr mutants show apoptotic loss of hemocytes over
ability to rescue hemocyte aggregation in Pvr mutant the course of embryonic development. The underlying
embryos. deficiency in trophic cell survival can be rescued by
Hemocyte-specific expression of the constitutively p35-mediated caspase inhibition, activated Ras, and, in
active PVR served as a control for Pvr1rescues that the early stages of embryonic development, activated
promote uniform activation of signaling pathways: Cell PI3K signaling.
morphology was reverted to dispersed EGFP-positive
hemocytes with single -gal-positive nuclei, and blood PVR Signaling Is Essential for Trophic Survival
cells were distributed evenly in all anterior and dorsal of a Hemocyte Cell Line
areas of the embryo (Figure 4C). Expression of activated To distinguish whether PVR signaling is required for
Ras1 rescued Pvr1 with similar efficiency (Figure 4D). On hemocytes to reach a trophic target within the embryo,
the contrary, expression of p110CAAX had only mild effects or whether PVR itself can trigger antiapoptotic cell sur-
on Pvr1 blood cell aggregates of stage 16 embryos (Fig- vival, we studied survival of a hemocyte cell line in cul-
ture. The embryonic cell line Kc 167 (Echalier andure 4E), and combination of p35 and activated p110CAAX
Developmental Cell
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Figure 4. Rescue of Hemocyte Apoptosis Reverts Blood Cell Aggregation
(A–G) In a Pvr1/Pvr1 mutant background, the indicated rescue constructs were expressed using the hemocyte-specific srpHemoGAL4. Blood
cells were marked by expression of membraneous/cytoplasmic srcEGFP and nuclear -gal (UAS-lacZnls). Stage 16 embryos are shown.
Dorsal views in left panels, and lateral views of projections through the whole embryo in middle panels. Right panels show red channel (-gal)
of middle panels. Asterisks indicate posterior end of embryos. Brackets mark hemocyte aggregates. Some images show autofluorescense
of the gut. (A) Pvr1/Pvr1. (B) Rescue by p35. (C) Rescue by PVR. (D) Rescue by RasV12. (E) Rescue by p110CAAX. (F) Rescue by p35 and p110CAAX.
In (B)–(D) and (F), no blood cell aggregates are seen and cells migrate dorsally up to the posterior end (asterisk). Cell distribution into the ventral-
posterior area remains incomplete (arrowheads). (G) Rescue by wtPVR. (H) Wild-type control (srpHemoGAL4,UAS-srcEGFP; UAS-lacZnls).
(I–L) Close-up images of the marked areas in (A) and (B), single optical sections. (I and J) Hemocyte morphology of Pvr1/Pvr1 shown in (A). (K
and L) Blood cell morphology of Pvr1, rescued by p35 expression as shown in (B).
(M and N) Costaining with anti-cleaved Caspase 3 (CC3) to mark apoptotic cells. Hemocytes in the anterior region of stage 14 embryos, single
optical sections. (M) Pvr1,UAS-srcEGFP/ Pvr1,UAS-srcEGFP;UAS-lacZnls. CC3signal colocalizes with both EGFP and -gal in some (bracket,
arrowhead) but not all hemocytes. (N) wild-type control (srpHemoGAL4,UAS-srcEGFP; UAS-lacZnls) shows CC3 staining in apoptotic corpses
of non-hemocyte origin only.
Ohanessian, 1970) displays hemocyte features, as cells macrophage marker Crq (data not shown). RT PCR anal-
ysis revealed endogenous expression of Pvr and its li-are able to phagocytose bacteria (Amy Kiger, Buzz
Baum, and N.P., unpublished data) and express the gand Pvf2 (not shown). Consistent with this finding, we
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Figure 5. Rescue of Hemocyte Apoptosis Restores Blood Cell Counts
Statistical comparison of blood cell counts in wild-type, Pvr loss-of-function, and rescued embryos. Cells were marked by nuclear -gal driven
by srpHemoGAL4. Error bars represent standard deviation from average. Indistinguishable misshapen -gal-positive structures were counted
as single cells. See Supplemental Data for average hemocyte numbers. See Experimental Procedures for genotypes.
detected PVR protein in its tyrosine phosphorylated Discussion
form in extracts of normally growing Kc cells (not
shown), indicating constitutive PVR activation, as it was PVR Controls Antiapoptotic Survival
of Blood Cellspreviously described for Drosophila S2 cells (Duchek et
al., 2001). To disrupt PVR signaling in Kc cells, we utilized Our results demonstrate that PVR controls the trophic
survival of embryonic blood cells in vivo and an embry-RNA interference (RNAi), treating cells with double-
stranded RNAs (dsRNAs) corresponding to the Pvr gene. onic hemocyte cell line in vitro. Inhibition of PVR signal-
ing or loss of Pvr function results in caspase-dependentLoss of PVR protein was confirmed by Western blot
(Supplemental Figure S2A). Upon Pvr silencing, we ob- apoptotic hemocyte death and formation of large blood
cell aggregates. Blood cell clustering in Pvr mutant em-served reduced total cell numbers and an increasing
rate of dead cells, as characterized by their permeability bryos has previously been interpreted as a migration
defect (Cho et al., 2002). Based on our findings we pro-to trypan blue. Cell death occurred over the course of
several days (Figure 6A). Cell cycle analysis quantifying pose a different scenario: Dying hemocytes lose their
ability to migrate, which may happen in many casesDNA contents by propidium iodide staining and FACS
analysis confirmed that Pvr RNAi did not lead to a gen- before cells leave the anterior locations of their origin.
The resulting apoptotic corpses pose a strong attractanteral cell cycle arrest (Figure 6B). We found an elevation
in the sub-G0 peak of the profile (Figure 6B and Supple- for their still-viable peer macrophages, which migrate
toward them to fulfil their phagocytic function. Subse-mental Figure S2B), indicative of increased cell death.
To specifically characterize apoptotic cell death, we per- quently, cannibalistic phagocytosis leads to engorge-
ment of macrophages with multiple blood cell corpsesformed TUNEL staining for fragmented nuclear DNA
(Figure 6C). As indicated by a shift in fluorescent emis- and results in the overall appearance of large hemocyte
aggregates (Figure 7).sion, an increasingly large proportion of cells tested
TUNEL-positive in Pvr-silenced cultures after 2 and 4 Blood cell death in Pvr mutants occurs progressively
throughout embryonic development. While hemocytedays of treatment (Supplemental Figure S2C), consistent
with DNA fragmentation preceding the breakdown of clustering in Pvr1 and Pvr4 becomes evident at different
stages of embryonic development, blood cell aggre-cellular integrity. Taken together, these results demon-
strate a requirement for PVR signaling in the trophic gates persist until the end of embryogenesis and inten-
sify over time. This is consistent with our observationssurvival of Kc cells in culture and support an antiapo-
ptotic function for PVR in embryonic hemocytes in vivo. in the hemocyte cell line Kc 167, where silencing of Pvr
Developmental Cell
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Figure 6. PVR Signaling Mediates Survival of the Hemocyte Cell Line Kc 167
Endogenous PVR signaling of Kc cells was disrupted by Pvr RNAi. For controls, GFP dsRNA was used.
(A) Loss of PVR results in reduced total cell numbers and elevated fractions of dead cells over time. In Pvr silenced cultures, live cell numbers
were reduced to 23% of control cells at day 2, and 13% at day 4 after treatment. A fraction of live cells continued to be present beyond the
fourth day of culture (not shown).
(B) Cell cycle analysis. Four days after addition of dsRNAs, adherent cells were stained with propidium iodide and were subjected to FACS
analysis. Data are corrected for doublets.
(C) TUNEL staining for apoptotic cells. At day 2, 35% of Pvr dsRNA-treated cells stained TUNEL-positive (note left shoulder of live cells), while
at day 4, 45% stained positive. Compare TUNEL-positive fluorescence to “no enzyme” control as reference for unspecific labeling background.
(B and C) For FACS histogram statistics, see Supplemental Figure S2.
results in apoptotic cell death over the course of days. systems that rely on reshaping by the phagocytic activity
of macrophages.Slow hemocyte death suggests activity of other partially
redundant signaling pathways supporting cell survival.
The Jak/Stat and Toll/Cactus pathways have been pro- Relay of the PVR Trophic Survival Signal
Trophic survival is well known in mammalian systems,posed to play roles in larval hemocyte survival (Govind,
1999; Mathey-Prevot and Perrimon, 1998), and it re- where it serves as an important mechanism to control
cell number (Raff et al., 1993): Extracellular factors pro-mains to be shown whether these pathways have a tro-
phic function in the embryonic hematopoietic system. duced by target tissues trigger survival pathways that
suppress apoptotic cell death and thereby control cellFurther, it needs to be determined whether Pvr mutant
blood cells die in a stochastic manner, or whether mac- number. In Drosophila, few rare described cases of anti-
apoptotic survival signaling are mediated through acti-rophages comprise different sublineages with variable
dependence on trophic PVR signaling. While our studies vation of the Drosophila EGFR (DER) by its ligands Vein
or Spitz in the survival of glia cells (Bergmann et al.,indicate that both dying and actively phagocytosing
blood cells express the same macrophage markers, 2002; Hidalgo et al., 2001), and by both ligands in the
survival of smooth cuticle cells (Urban et al., 2004). Otheridentification of additional markers may reveal a distinc-
tion between sublineages. signaling pathways may have similar roles during devel-
opment (Abrams, 2002; Hidalgo, 2002), but detailedDefects in hemocyte function may indirectly account
for the associated lethality of Pvr mutants. Studies by analysis is often limited. In accordance with the classical
model of trophic cues, the PVR ligands PVF1-3 are ex-Sears et al. (2003) have demonstrated that Pvr mutants
suffer from secondary defects in the morphogenesis of pressed dynamically in multiple embryonic tissues
throughout embryogenesis (Cho et al., 2002). Only simul-the embryonic central nervous system. These defects
are caused by a failure of hemocytes to remove dead taneous RNAi silencing of all three ligands leads to he-
mocyte aggregation (Cho et al., 2002), consistent withcells, as similar effects were seen in embryos which lack
srp function, or in which phagocytosis was impaired PVF1-3 providing the crucial stimuli for hemocyte sur-
vival by activation of PVR.(Sears et al., 2003). It is likely that additional secondary
defects of Pvr mutants will be found in other organ Our Pvr mutant rescue experiments demonstrate that
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Figure 7. Model for PVR Function in Embryonic Blood Cell Development and Survival
(A) Wild-type embryo. During germ band retraction, hemocytes separate into two groups that populate the embryo from the anterior and
posterior ends (arrows). PVR has at least two roles in embryonic blood cells: (1) Throughout embryogenesis, PVR function is essential for
trophic survival of hemocytes. (2) PVR activity allows hemocytes to enter the posterior end, and to subsequently distribute within the ventral
posterior area at later stages.
(B) Cannibalistic phagocytosis in Pvr mutants: Dying hemocytes stop migrating and attract viable peers, which phagocytose them according
to their natural function as macrophages. As a result, large aggregates of mislocalized blood cell clusters form. Note enlarged macrophages
with multiple apoptotic corpses.
(C) When viability is rescued, blood cells of Pvr mutants do not phagocytose each other any more and disperse from the anterior side (arrow).
As PVR function is necessary for some aspect of cell entry or migration into the posterior end (stage 12), we propose that this subpopulation
of hemocytes is not in reach to fill a gap in the ventral-posterior area, which is still evident at later stages (stage 17). Alternatively, PVR may
support aspects of hemocyte migration necessary to reach targets in the ventral-posterior area.
Crystal cells shown in gray. Gut and nervous system (light gray) shown for orientation purposes.
activated Ras is sufficient to restore hemocyte survival. the observed effect, consistent with a current model for
apoptosis in Drosophila (Danial and Korsmeyer, 2004).This result resembles findings from survival signaling by
DER, which was shown to inhibit action of the proapo- Regardless of the upstream pathways involved, inhibi-
tion of caspases by the baculovirus inhibitor of apopto-ptotic protein HID by phosphorylation through Ras-acti-
vated MAPK (Bergmann et al., 1998). As PVR signaling sis p35 was sufficient to rescue the Pvr mutant hemocyte
death and aggregation phenotype. In these rescue ex-triggers MAPK activation in Schneider cells (Duchek et
al., 2001) and may have the same effect in embryonic periments, p35 appeared slightly less potent than RasV12,
which may be due to the inability of p35 to inhibit thehemocytes (Cho et al., 2002), it is likely that the Ras/
MAPK pathway is a route of antiapoptotic PVR signaling. upstream caspase Dronc (Hawkins et al., 2000), or par-
tially insufficient expression levels, as p35 inhibits cas-Expression of dominant-negative RasN17 did not lead to
large hemocyte aggregates but induced mild enlarge- pases by stoichiometric binding (Danial and Kors-
meyer, 2004).ment of hemocytes at a low penetrance. This mild phe-
notype points to weak defects in blood cell survival. The
incomplete effect of RasN17 may be due to a number of Other Functions of PVR in Hemocytes
While activated PVR and other activated rescue trans-reasons. RasN17may be too weak to fully block endoge-
nous Ras signaling, or Ras signaling may be redundant genes reverted hemocyte clustering and cell death effi-
ciently, embryos still retained residual defects in hemo-with other signaling pathways that are active in PVR-
dependent cell survival. In Pvr1 rescue experiments, acti- cyte distribution. In stage 11/12 embryos, blood cell
entry into the posterior end of the elongated germ bandvated RasV12 was used, which was shown to ectopically
activate other signaling pathways such as the PI3K path- was affected (Figure 1 and data not shown), and in stage
15/16 embryos, the posterior area of the ventral nervousway (Prober and Edgar, 2002). Therefore, rescue by
RasV12 may involve a number of downstream pathways, system was lacking hemocytes. This is consistent with
Cho et al. (2002) who described a role for PVR in thebut the Ras/MAPK pathway itself may still be central to
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entry/migration of hemocytes into the posterior end of Antiapoptotic cell survival and its aberrant prolongation
are a major mechanism in the formation of human neo-stage 11/12 embryos. Since the natural route of hemo-
cytes is to distribute from the posterior end into ventral plasias (Evan and Vousden, 2001). In many cases, con-
nections to deregulated upstream signaling pathwaysposterior areas, we propose that the observed ventral-
posterior lack in hemocytes may reflect the initial inabil- remain unclear. Interestingly, in Acute Myeloid Leuke-
mias (AML), more than one-third of cases are associatedity of blood cells to invade, or migrate within, the poste-
rior end (Figure 7). Alternatively, PVR activity may be with specific activating mutations in the PDGF/VEGF
receptors Flt3 and c-Kit, and activating fusions ofrequired at multiple steps of embryonic hemocyte mi-
gration. In this case, defects at early steps of hemocyte PDGFR replace the more common oncogenic BCR-
ABL fusions in some cases of Chronic Myeloid Leukemiamigration (i.e., entry into the posterior end) may be more
readily visualized than defects at later steps, which may (CML) (Kelly and Gilliland, 2002). The contribution of
these and other disease-associated genes to aspects ofbe masked by additional independent mechanisms of
hemocyte dispersal. To distinguish between these pos- cell survival versus proliferation is still difficult to assess
in vivo (Huettner et al., 2000), yet their mechanism ofsibilities, more refined techniques to study blood cell
migration will be required. Consistent with both models, action is important for the selection of molecularly tar-
geted therapies. Drosophila embryonic hematopoiesisuniform expression of activated PVR in hemocytes
leads to a similar, yet milder, phenotype at a low pene- allows the in vivo study of blood cell survival indepen-
dent of cell proliferation, and our work has demonstratedtrance, suggesting that correct hemocyte entry or migra-
tion requires tightly controlled or locally asymmetric ac- the antiapoptotic potential of the Drosophila PDGF/
VEGF receptor and activated signaling componentstivation of PVR. By analogy, migration of border cells in
the egg chamber was dramatically affected by uniform such as RasV12. It will be interesting to exploit the system
further by testing disease-related genes of the sameactivation of PVR (Duchek et al., 2001), revealing a role
for locally asymmetric PVR activation in the guidance of and particularly other families for their in vivo potential
to rescue blood cell survival in Drosophila. Complemen-border cells (Duchek et al., 2001; McDonald et al., 2003).
In mammals, PDGF/VEGF receptors are known to me- tary to our in vivo findings, we have established a Dro-
sophila cell culture system for the study of PVR-depen-diate additional cellular responses, such as cell prolifer-
ation and differentiation (Hoch and Soriano, 2003; Neu- dent blood cell survival. Genome-wide RNAi screens
(Boutros et al., 2004) will allow identification of modifiersfeld et al., 1999). Drosophila PVF2 has been described
to promote proliferation of larval hemocytes (Munier et of PVR-dependent blood cell survival.
al., 2002). Our experiments do not point to a role for
Experimental ProceduresPVR in the proliferation of embryonic blood cells, as Pvr
RNAi-treated Kc cells did not show an obvious arrest
Constructs and Fly Stocksin the cell cycle, and p35 was sufficient to rescue blood
For construction of transgenes pUAST-PVRC, pCaSpeR4-srp
cell counts in mutant embryos. As blood cell proliferation HemoGAL4, pCaSpeR-tubulin-PVR, and for EMS mutagenesis
occurs very early during embryonic development, we see Supplemental Data (http://www.developmentalcell.com/cgi/
cannot exclude, however, that an unnoticed maternal content/full/7/1/73/DC1). Genotypes in Pvr rescue experiments
were: UAS-p110CAAX/ ; Pvr1,UAS-srcEGFP/ Pvr1, srpHemoGAL4;contribution of Pvr may obscure a role for the receptor
UAS-lacZnls/  or Pvr1,UAS-srcEGFP/ Pvr1, srpHemoGAL4; UAS-in embryonic hemocyte proliferation in vivo. Likewise,
rescue/ UAS-lacZnls (for rescue constructs UAS-PVR, UAS-p35,with respect to blood cell differentiation, we did not
UAS-RasV12/ TM3,ftzlacZ). For the combined rescue by p110CAAX
detect effects of Pvr loss-of-function on macrophage and p35, the examined genotype was: UAS-p110CAAX/ ; Pvr1,UAS-
differentiation as judged by the marker Crq. Neverthe- srcEGFP/ Pvr1, srpHemoGAL4; UAS-p35/ UAS-lacZnls. The corre-
less, a role for PVR in hemocyte differentiation may be- sponding genotypes of heteroallelic combinations with Pvr4 con-
tained instead: Pvr4,UAS-srcEGFP/ Pvr1, srpHemoGAL4.come apparent once more specific lineage markers will
be available.
Stainings and MicroscopyTaken together, PVR has at least two functions in
Embryo stainings were visualized by DAB (Vector) or fluorescentlythe embryonic hematopoietic system (Figure 7): (1) PVR
labeled secondary antibodies (Molecular Probes, Jackson) and con-mediates antiapoptotic survival of blood cells through-
focal microscopy (TCSNT, Leica). Primary antibodies used were:
out embryonic development, and (2) PVR is required for anti-Crq (Franc et al., 1996), anti-Pxn (Abrams et al., 1993; Nelson
invasion into/migration within the posterior end of the et al., 1994), anti-Lz (Lebestky et al., 2000), anti-PVR (Duchek et
embryo. Rescue of cell viability reverts the dramatic al., 2001 and McDonald et al., 2003), anti-GFP (Molecular Probes,
Cappel), anti--Gal (Promega), anti-cleaved Caspase 3 (CC3) (Cellblood cell aggregation phenotype and leads to dispersal
Signaling). For stainings with anti-CC3, embryos were devittelinizedof cells in anterior and dorsal areas of the embryo.
by hand. Confocal images are projections of eight optical sections
representing approximately one-half of the embryo unless stated
A Model System for Blood Cell Survival otherwise. Hemocyte counts were taken under fluorescent micros-
in Development and Disease copy, assessing at least four independent embryos per genotype
and stage. Embryo graphics of Figure 7 according to HartensteinThe role of Drosophila PVR in trophic cell survival em-
(1993).phasizes the high degree of conservation between Dro-
sophila and vertebrate PDGF/VEGF family receptor
Cell Culture and Flow Cytometry Analysisfunction. Our in vivo and cell culture work now provides
Kc 167 cells (Echalier and Ohanessian, 1970) were grown underthe basis to study cell survival in a simple but highly
standard conditions (Bru¨ckner et al., 2000). dsRNAs were prepared
conserved hematopoietic system. In vertebrates, con- from the following regions: Pvr internal, 501 nt (starting at GCA
trol of cell survival is an important aspect of hematopoie- CAACCCT), Pvr 3UTR, 429 nt (starting at GACGTCCCGG), GFP nt
3–549 of ORF, using the Ambion MegaScript kit. 2  106cells/6-wellsis and stem cell maintenance (Lotem and Sachs, 2002).
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were seeded. dsRNA treatment of cells was performed according RNA interference in Drosophila cell lines to dissect signal transduc-
tion pathways. Proc. Natl. Acad. Sci. USA 97, 6499–6503.to Clemens et al. (2000), using 12 g dsRNA/well, with correspond-
ing total amounts of dsRNA for Pvr and GFP controls. After incuba- Danial, N.N., and Korsmeyer, S.J. (2004). Cell death: critical control
tions as indicated, all cells were collected, pelleted, and resus- points. Cell 116, 205–219.
pended in Schneider’s medium (GIBCO). For trypan blue stainings, Duchek, P., Somogyi, K., Jekely, G., Beccari, S., and Rørth, P. (2001).
cell suspensions were mixed at equal volume with trypan blue (0.4%) Guidance of cell migration by the Drosophila PDGF/VEGF receptor.
and counted in a hemacytometer. 2 ml of this suspension corre- Cell 107, 17–26.
spond to the culture of a 6-well. For each experiment, several fields
Echalier, G., and Ohanessian, A. (1970). In vitro culture of Drosophilawere counted. Direct TUNEL labeling was done according to the
melanogaster embryonic cells. In Vitro 6, 162–172.manufacturer’s instructions (Roche). For cell cycle analysis, adher-
Evan, G.I., and Vousden, K.H. (2001). Proliferation, cell cycle andent cells were washed and harvested, and 106 cells were incubated
apoptosis in cancer. Nature 411, 342–348.in 250 l of staining solution (PBS, 1% Tween 20, 100 g RNaseA
[Sigma], 50 g Propidium Iodide) for 2 hr. FACS analysis was per- Evans, C.J., Hartenstein, V., and Banerjee, U. (2003). Thicker than
formed on a FACSCalibur (Becton-Dickinson) and CellQuest soft- blood: conserved mechanisms in Drosophila and vertebrate hema-
ware, analyzing 5000 (TUNEL)/50,000 (PI) events per measurement. topoiesis. Dev. Cell 5, 673–690.
SDS-PAGE and Western blot analysis were done as described Ferrara, N., and Davis-Smyth, T. (1997). The biology of vascular
(Bru¨ckner et al., 2000). Guinea pig anti-PVR antiserum was raised endothelial growth factor. Endocr. Rev. 18, 4–25.
against the PVR C-terminal peptide NYVNMKPPRKNIPGKTTT.
Fossett, N., and Schulz, R.A. (2001). Functional conservation of he-
matopoietic factors in Drosophila and vertebrates. Differentiation
Acknowledgments 69, 83–90.
Franc, N.C. (2002). Phagocytosis of apoptotic cells in mammals,We thank L. Fessler, A. Ezekowitz, D. Montell, and U. Banerjee for
caenorhabditis elegans and Drosophila melanogaster: moleculargenerous gifts of antibodies; B. Mathey-Prevot, S. Beckendorf, J.
mechanisms and physiological consequences. Front. Biosci. 7,Abrams, M. Halfon, M. Krasnow, K. Ga¨ngel, E. Bach, E. Spana,
D1298–D1313.and X. Lin for fly stocks; and J. Kopinja, C. Villalta, and A.Voie for
Franc, N.C., and White, K. (2000). Innate recognition systems intransgenic strains. We thank B. Mathey-Prevot, H. Agaisse, A. Kiger,
insect immunity and development: new approaches in Drosophila.P. Bradley, S. Vincent, L. Kelly, J. Zeitlinger, and members of the
Microbes Infect. 2, 243–250.Perrimon lab for helpful discussions and critical reading of the manu-
script. K.B. thanks H. Babbe for advice and help with FACS cell Franc, N.C., Dimarcq, J.L., Lagueux, M., Hoffmann, J., and Ezeko-
cycle analysis and E. Bach for introduction to FACS analysis. K.B. witz, R.A. (1996). Croquemort, a novel Drosophila hemocyte/macro-
was supported by EMBO and HFSP postdoctoral fellowships and phage receptor that recognizes apoptotic cells. Immunity 4,
is a Special Fellow of the Leukemia and Lymphoma Society. L.K. is 431–443.
supported by a postdoctoral fellowship of the DOD Breast Cancer Franc, N.C., Heitzler, P., Ezekowitz, R.A., and White, K. (1999). Re-
Research Program, DAMD17-02-1-0401. N.P. is an investigator of quirement for croquemort in phagocytosis of apoptotic cells in Dro-
the Howard Hughes Medical Institute. sophila. Science 284, 1991–1994.
Franke, T.F., Kaplan, D.R., and Cantley, L.C. (1997). PI3K: down-
Received: January 20, 2004 stream AKTion blocks apoptosis. Cell 88, 435–437.
Revised: April 22, 2004
Gerber, H.P., and Ferrara, N. (2003). The role of VEGF in normal andAccepted: April 28, 2004
neoplastic hematopoiesis. J. Mol. Med. 81, 20–31.Published: July 12, 2004
Gerber, H.P., Malik, A.K., Solar, G.P., Sherman, D., Liang, X.H., Meng,
G., Hong, K., Marsters, J.C., and Ferrara, N. (2002). VEGF regulatesReferences
haematopoietic stem cell survival by an internal autocrine loop
mechanism. Nature 417, 954–958.Abrams, J.M. (2002). Competition and compensation: coupled to
Govind, S. (1999). Control of development and immunity by rel tran-death in development and cancer. Cell 110, 403–406.
scription factors in Drosophila. Oncogene 18, 6875–6887.Abrams, J.M., White, K., Fessler, L.I., and Steller, H. (1993). Pro-
Hartenstein, V. (1993). Atlas of Drosophila Development. (Coldgrammed cell death during Drosophila embryogenesis. Develop-
Spring Harbor, NY: Cold Spring Harbor Laboratory Press).ment 117, 29–43.
Hawkins, C.J., Yoo, S.J., Peterson, E.P., Wang, S.L., Vernooy, S.Y.,Ashman, L.K. (1999). The biology of stem cell factor and its receptor
and Hay, B.A. (2000). The Drosophila caspase DRONC cleaves fol-C-kit. Int. J. Biochem. Cell Biol. 31, 1037–1051.
lowing glutamate or aspartate and is regulated by DIAP1, HID, andBergmann, A., Agapite, J., McCall, K., and Steller, H. (1998). The
GRIM. J. Biol. Chem. 275, 27084–27093.Drosophila gene hid is a direct molecular target of Ras-dependent
Hay, B.A., Wolff, T., and Rubin, G.M. (1994). Expression of baculovi-survival signaling. Cell 95, 331–341.
rus P35 prevents cell death in Drosophila. Development 120, 2121–Bergmann, A., Tugentman, M., Shilo, B.Z., and Steller, H. (2002).
2129.Regulation of cell number by MAPK-dependent control of apoptosis:
Heino, T.I., Karpanen, T., Wahlstrom, G., Pulkkinen, M., Eriksson,a mechanism for trophic survival signaling. Dev. Cell 2, 159–170.
U., Alitalo, K., and Roos, C. (2001). The Drosophila VEGF receptorBoutros, M., Kiger, A.A., Armknecht, S., Kerr, K., Hild, M., Koch, B.,
homolog is expressed in hemocytes. Mech. Dev. 109, 69–77.Haas, S.A., Consortium, H.F., Paro, R., and Perrimon, N. (2004).
Hidalgo, A. (2002). Interactive nervous system development: controlGenome-wide RNAi analysis of growth and viability in Drosophila
of cell survival in Drosophila. Trends Neurosci. 25, 365–370.cells. Science 303, 832–835.
Hidalgo, A., Kinrade, E.F., and Georgiou, M. (2001). The DrosophilaBrand, A.H., and Perrimon, N. (1993). Targeted gene expression as
neuregulin vein maintains glial survival during axon guidance in thea means of altering cell fates and generating dominant phenotypes.
CNS. Dev. Cell 1, 679–690.Development 118, 401–415.
Hoch, R.V., and Soriano, P. (2003). Roles of PDGF in animal develop-Bru¨ckner, K., Perez, L., Clausen, H., and Cohen, S. (2000). Glycosyl-
ment. Development 130, 4769–4784.transferase activity of Fringe modulates Notch-Delta interactions.
Nature 406, 411–415. Hoffmann, J.A., and Reichhart, J.M. (2002). Drosophila innate immu-
nity: an evolutionary perspective. Nat. Immunol. 3, 121–126.Cho, N.K., Keyes, L., Johnson, E., Heller, J., Ryner, L., Karim, F.,
and Krasnow, M.A. (2002). Developmental control of blood cell mi- Holz, A., Bossinger, B., Strasser, T., Janning, W., and Klapper, R.
gration by the Drosophila VEGF pathway. Cell 108, 865–876. (2003). The two origins of hemocytes in Drosophila. Development
130, 4955–4962.Clemens, J.C., Worby, C.A., Simonson-Leff, N., Muda, M., Maehama,
T., Hemmings, B.A., and Dixon, J.E. (2000). Use of double-stranded Huettner, C.S., Zhang, P., Van Etten, R.A., and Tenen, D.G. (2000).
Developmental Cell
84
Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat. Urban, S., Brown, G., and Freeman, M. (2004). EGF receptor signal-
ling protects smooth-cuticle cells from apoptosis during DrosophilaGenet. 24, 57–60.
ventral epidermis development. Development 131, 1835–1845.Jacobson, M.D., Weil, M., and Raff, M.C. (1997). Programmed cell
Waskow, C., Paul, S., Haller, C., Gassmann, M., and Rodewald, H.death in animal development. Cell 88, 347–354.
(2002). Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in theKelly, L.M., and Gilliland, D.G. (2002). Genetics of myeloid leukemias.
maintenance of lymphopoiesis. Immunity 17, 277–288.Annu. Rev. Genomics Hum. Genet. 3, 179–198.
Lanot, R., Zachary, D., Holder, F., and Meister, M. (2001). Postembry-
onic hematopoiesis in Drosophila. Dev. Biol. 230, 243–257.
Lebestky, T., Chang, T., Hartenstein, V., and Banerjee, U. (2000).
Specification of Drosophila hematopoietic lineage by conserved
transcription factors. Science 288, 146–149.
Lotem, J., and Sachs, L. (2002). Cytokine control of developmental
programs in normal hematopoiesis and leukemia. Oncogene 21,
3284–3294.
Mathey-Prevot, B., and Perrimon, N. (1998). Mammalian and Dro-
sophila blood: JAK of all trades? Cell 92, 697–700.
McDonald, J.A., Pinheiro, E.M., and Montell, D.J. (2003). PVF1, a
PDGF/VEGF homolog, is sufficient to guide border cells and inter-
acts genetically with Taiman. Development 130, 3469–3478.
Munier, A.I., Doucet, D., Perrodou, E., Zachary, D., Meister, M.,
Hoffmann, J.A., Janeway, C.A., Jr., and Lagueux, M. (2002). PVF2,
a PDGF/VEGF-like growth factor, induces hemocyte proliferation in
Drosophila larvae. EMBO Rep. 3, 1195–1200.
Nelson, R.E., Fessler, L.I., Takagi, Y., Blumberg, B., Keene, D.R.,
Olson, P.F., Parker, C.G., and Fessler, J.H. (1994). Peroxidasin: a
novel enzyme-matrix protein of Drosophila development. EMBO J.
13, 3438–3447.
Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. (1999).
Vascular endothelial growth factor (VEGF) and its receptors. FASEB
J. 13, 9–22.
Peterson, J.S., Barkett, M., and McCall, K. (2003). Stage-specific
regulation of caspase activity in Drosophila oogenesis. Dev. Biol.
260, 113–123.
Prober, D.A., and Edgar, B.A. (2002). Interactions between Ras1,
dMyc, and dPI3K signaling in the developing Drosophila wing.
Genes Dev. 16, 2286–2299.
Raff, M.C., Barres, B.A., Burne, J.F., Coles, H.S., Ishizaki, Y., and
Jacobson, M.D. (1993). Programmed cell death and the control of
cell survival: lessons from the nervous system. Science 262,
695–700.
Rehorn, K.P., Thelen, H., Michelson, A.M., and Reuter, R. (1996).
A molecular aspect of hematopoiesis and endoderm development
common to vertebrates and Drosophila. Development 122, 4023–
4031.
Rizki, T.M. (1978). The circulatory system and associated cells and
tissues. In The Genetics and Biology of Drosophila 2b, M. Ashburner
and T.R.F. Wright, Eds. (New York: Academic Press), 397–452.
Rizki, T.M., and Rizki, R.M. (1992). Lamellocyte differentiation in
Drosophila larvae parasitized by Leptopilina. Dev. Comp. Immunol.
16, 103–110.
Scanga, S.E., Ruel, L., Binari, R.C., Snow, B., Stambolic, V., Bou-
chard, D., Peters, M., Calvieri, B., Mak, T.W., Woodgett, J.R., and
Manoukian, A.S. (2000). The conserved PI3K/PTEN/Akt signaling
pathway regulates both cell size and survival in Drosophila. Onco-
gene 19, 3971–3977.
Scheijen, B., and Griffin, J.D. (2002). Tyrosine kinase oncogenes in
normal hematopoiesis and hematological disease. Oncogene 21,
3314–3333.
Sears, H.C., Kennedy, C.J., and Garrity, P.A. (2003). Macrophage-
mediated corpse engulfment is required for normal Drosophila CNS
morphogenesis. Development 130, 3557–3565.
Stanley, E.R., Berg, K.L., Einstein, D.B., Lee, P.S., Pixley, F.J., Wang,
Y., and Yeung, Y.G. (1997). Biology and action of colony–stimulating
factor-1. Mol. Reprod. Dev. 46, 4–10.
Tepass, U., Fessler, L.I., Aziz, A., and Hartenstein, V. (1994). Embry-
onic origin of hemocytes and their relationship to cell death in Dro-
sophila. Development 120, 1829–1837.
